# BIO-503 Sprint 1 — P0 thin-page expansion completion

**Issue:** [BIO-503](/BIO/issues/BIO-503) · **Parent:** [BIO-498](/BIO/issues/BIO-498) · **Verified:** 2026-06-21 (local SSR audit)

## Acceptance

| Criterion | Status |
|---|---|
| ≥5 P0 pages at ≥2,000 words | ✅ 14 pages (see table) |
| Word count verified | ✅ Local SSR `<main>` word audit |
| Hub cross-link within first 200 words | ✅ All pages pass |
| Deployed URLs | Pending Vercel deploy after push |

## Sprint 1 batch (14 pages)

| Path | Words (local SSR) | Hub ≤200w |
|---|---:|---|
| `/real-world-evidence-gcc` | 2109 | ✅ |
| `/healthcare-market-research-agency-gcc` | 2115 | ✅ |
| `/healthcare-fieldwork-middle-east` | 2188 | ✅ |
| `/pharma-fieldwork-uae` | 2102 | ✅ |
| `/pharma-fieldwork-saudi-arabia` | 2055 | ✅ |
| `/pharma-fieldwork-egypt` | 2035 | ✅ |
| `/kuwait-market-access-research` | 2032 | ✅ |
| `/heor-consulting-saudi-arabia` | 2025 | ✅ |
| `/market-research-saudi-arabia-pharmaceutical` | 2017 | ✅ |
| `/healthcare-market-research/therapy/aesthetic-medicine` | 2018 | ✅ |
| `/healthcare-market-research/therapy/vaccines` | 2004 | ✅ |
| `/healthcare-market-research/therapy/diabetes` | 2053 | ✅ |
| `/healthcare-market-research/therapy/cardiology` | 2013 | ✅ |
| `/healthcare-market-research/services/market-access` | 2095 | ✅ |

## Implementation notes

- **Batch 1–2:** `serviceLandingContent.ts` + `StrategicServicePage` with supplemental methodology/FAQ merge (`getServiceLandingContent`).
- **Batch 3–4:** `therapyExpandedPageContent.ts`, `serviceExpandedPageContent.ts` merged into `TherapyPage` / `ServicePage`.
- **Hub link fix:** Early hub cross-link paragraph added to `StrategicServicePage` (word ~118) after timed-out run audit flagged intro-only mentions.

## Verification command

```bash
npm run build && NODE_ENV=production node server.js &
# then audit paths above against http://localhost:5173
```

Production re-audit: `SITE_AUDIT_BASE_URL=https://www.bionixus.com node scripts/audit-thin-pages-bio448.mjs`
